Estrogen Receptor (ER) β or p53 Attenuates ERα-mediated Transcriptional Activation on the BRCA2 Promoter

This publication has 31 references indexed in Scilit:

• Hallmarks of 'BRCAness' in sporadic cancers
  Nature Reviews Cancer, 2004
• Coordinated histone modifications mediated by a CtBP co-repressor complex
  Nature, 2003
• A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor α coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA
  The EMBO Journal, 2001
• Induction of the BRCA2 Promoter by Nuclear Factor-κB
  Journal of Biological Chemistry, 2000
• The Contribution of Germline BRCA1 and BRCA2 Mutations to Familial Ovarian Cancer: No Evidence for Other Ovarian Cancer–Susceptibility Genes
  American Journal of Human Genetics, 1999
• Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
  Endocrine Reviews, 1999
• DecreasedBRCA1Expression Levels May Arrest the Cell Cycle through Activation ofp53Checkpoint in Human Sporadic Breast Tumors
  Biochemical and Biophysical Research Communications, 1998
• The CBP co-activator is a histone acetyltransferase
  Nature, 1996
• The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
  Published by Elsevier ,1996
• Survival with breast cancer: the importance of estrogen receptor quantity
  European Journal of Cancer and Clinical Oncology, 1989